CSAM Health Group AS
Omda AS provides software solutions for healthcare sector in Norway, Sweden, Denmark, and internationally. The company offers laboratory information management systems consist of CSAM ProSang, a blood, cell, and tissue management system; and medical medication solution comprising CSAM Cytodose, an oncology treatment management solution. It also provides connected healthcare solutions, including O… Read more
CSAM Health Group AS (CSAMF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2025: -0.665x
Based on the latest financial reports, CSAM Health Group AS (CSAMF) has a cash flow conversion efficiency ratio of -0.665x as of March 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-21.70 Million) by net assets ($32.64 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
CSAM Health Group AS - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how CSAM Health Group AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
CSAM Health Group AS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CSAM Health Group AS ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PWO AG
LSE:0NHL
|
N/A |
|
AEC SECURITIES
BK:BYD-R
|
N/A |
|
Huhtamaki India Limited
NSE:HUHTAMAKI
|
0.184x |
|
Readly International AB
ST:READ
|
0.372x |
|
APG Securities Joint Stock Co
VN:APG
|
N/A |
|
AIRTIF.INTEL.STR. EO-09
F:IRG
|
N/A |
|
Truong Thanh Furniture Corp
VN:TTF
|
N/A |
|
Perak Transit Bhd
KLSE:0186
|
0.030x |
Annual Cash Flow Conversion Efficiency for CSAM Health Group AS (2018–2024)
The table below shows the annual cash flow conversion efficiency of CSAM Health Group AS from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $24.68 Million | $132.25 Million | 5.359x | +1211.75% |
| 2023-12-31 | $95.26 Million | $38.92 Million | 0.409x | +1.04% |
| 2022-12-31 | $28.77 Million | $11.63 Million | 0.404x | +206.49% |
| 2021-12-31 | $166.60 Million | $21.98 Million | 0.132x | +15.76% |
| 2020-12-31 | $248.35 Million | $28.30 Million | 0.114x | -92.54% |
| 2019-12-31 | $34.20 Million | $52.25 Million | 1.528x | +310.30% |
| 2018-12-31 | $60.33 Million | $22.47 Million | 0.372x | -- |